http://rdf.ncbi.nlm.nih.gov/pubmed/1991974

http://rdf.ncbi.nlm.nih.gov/pubmed/1991974

http://rdf.ncbi.nlm.nih.gov/pubmed/1991974

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• ll
  http://metadb.riken.jp/db/mgi_rdf/MGI:1856937

class

http://purl.org/net/cito/citesAsAuthority

• ll
  http://metadb.riken.jp/db/mgi_rdf/MGI:1856937

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• extended life span_ll/ll,X/Yaa
  http://metadb.riken.jp/0001661BXSBMpJScrllllllXYaallYaa
• decreased IgG level_ll/ll,X/Yaa
  http://metadb.riken.jp/0001805BXSBMpJScrllllllXYaallYaa
• decreased CD4-positive, alpha beta T cell number_ll/ll,X/Yaa
  http://metadb.riken.jp/0008075BXSBMpJScrllllllXYaallYaa
• increased monocyte cell number_X/Yaa
  http://metadb.riken.jp/0000220BXSBMpJScrXYaaYaa
• abnormal monocyte morphology_ll/ll,X/Yaa
  http://metadb.riken.jp/0002620BXSBMpJScrllllllXYaallYaa
• decreased CD4-positive, alpha beta T cell number_X/Yaa
  http://metadb.riken.jp/0008075BXSBMpJScrXYaaYaa
• increased susceptibility to autoimmune disorder_X/Yaa
  http://metadb.riken.jp/0005350BXSBMpJScrXYaaYaa
• premature death_X/Yaa
  http://metadb.riken.jp/0002083BXSBMpJScrXYaaYaa
• increased IgG level_X/Yaa
  http://metadb.riken.jp/0002493BXSBMpJScrXYaaYaa
• increased T cell derived lymphoma incidence_ll/ll,X/Yaa
  http://metadb.riken.jp/0002024BXSBMpJScrllllllXYaallYaa
• glomerulonephritis_X/Yaa
  http://metadb.riken.jp/0002743BXSBMpJScrXYaaYaa
• increased anti-nuclear antigen antibody level_X/Yaa
  http://metadb.riken.jp/0004794BXSBMpJScrXYaaYaa
• decreased susceptibility to autoimmune disorder_ll/ll,X/Yaa
  http://metadb.riken.jp/0005351BXSBMpJScrllllllXYaallYaa
• increased lymphoma incidence_ll/ll,X/Yaa
  http://metadb.riken.jp/0012431BXSBMpJScrllllllXYaallYaa
• decreased anti-nuclear antigen antibody level_ll/ll,X/Yaa
  http://metadb.riken.jp/0004795BXSBMpJScrllllllXYaallYaa